UnitedHealth Group Stock Slumps Amid DOJ Investigation

Shares of UnitedHealth Group fell following news of a Department of Justice investigation. The probe examines billing practices tied to its Medicare Advantage plans. Recent company challenges include rising care use and leadership changes. This comes amid broader financial difficulties, with shares down significantly from last year's peak.


Devdiscourse News Desk | Edenprairie | Updated: 24-07-2025 20:41 IST | Created: 24-07-2025 20:41 IST
UnitedHealth Group Stock Slumps Amid DOJ Investigation
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

Shares of health care giant UnitedHealth Group dropped after the company revealed it's under investigation by the Department of Justice. The investigation focuses on billing practices related to Medicare Advantage plans.

UnitedHealth emphasized its commitment to compliance and cooperation with authorities. The inquiry comes as UnitedHealth navigates challenges like increased healthcare usage and rate adjustments.

Compounding the company's troubles, stocks have declined substantially since the tragic shooting of its CEO, Brian Thompson, and subsequent executive changes, marking a turbulent period for the company ahead of its upcoming earnings report.

(With inputs from agencies.)

Give Feedback